Association between HbA1c Levels and Clinical Outcomes in Patients with Diabetes Mellitus and Melioidosis
Sam Guempel-Crothers1,2, Stuart Campbell3, Mirjam Kaestli1
1Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
Abstract:
Diabetes mellitus (DM) is the major clinical risk factor for melioidosis, though the effect of improved glycemic control on clinical outcomes is unknown. We investigated whether glycemic control affects clinical outcomes by analyzing a composite outcome of death or intensive care unit admission among patients from the Darwin Prospective Melioidosis Study, stratified by their glycosylated hemoglobin (HbA1c). A total of 292 patients with melioidosis and DM were identified with mean HbA1c of 10.2% (95% CI: 9.8-10.4). The composite outcome occurred in 74 (24.3%) patients, but it was not associated with HbA1c when analyzed by quartiles (P = 0.48) or as a continuous variable (P = 0.41). As in other studies, bacteremia remained the strongest factor associated with adverse outcomes (odds ratio: 9.68, 95% CI: 4.15-22.58, P <0.01). Unlike in other studies, age ≥50 years trended toward protection from death/ICU (P = 0.08). These data reflect continuing gaps in understanding the complex interplay of the immune system, DM, and melioidosis.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...


